Eosinophilic fasciitis associated with autoimmune thyroid disease and myelodysplasia treated with pulsed methylprednisolone and antihistamines.
Farrell
A M
AM
Ross
J S
JS
Bunker
C B
CB
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000150:complications* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000150:complications / Q000188:drug therapy*; D005208:Fasciitis / Q000150:complications / Q000188:drug therapy*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009436:Neural Tube Defects / Q000150:complications* / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D013959:Thyroid Diseases / Q000150:complications* / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D011239:Prednisolone; D008775:Methylprednisolone